Maidman S, Hegele R, Rosenson R
Curr Atheroscler Rep. 2024; 27(1):3.
PMID: 39541062
DOI: 10.1007/s11883-024-01258-8.
Kim M, Zheng Z
Trends Endocrinol Metab. 2024; 36(3):278-291.
PMID: 39191606
PMC: 11861388.
DOI: 10.1016/j.tem.2024.07.020.
Wheless A, Gunn K, Neher S
Subcell Biochem. 2024; 104:139-179.
PMID: 38963487
DOI: 10.1007/978-3-031-58843-3_8.
Liu G, Lai P, Guo J, Wang Y, Xian X
Med Rev (2021). 2023; 1(1):92-110.
PMID: 37724074
PMC: 10388752.
DOI: 10.1515/mr-2021-0004.
Sviridov D, Dasseux A, Reimund M, Pryor M, Drake S, Jarin Z
Front Cardiovasc Med. 2023; 10:1223920.
PMID: 37547254
PMC: 10403075.
DOI: 10.3389/fcvm.2023.1223920.
Apo CIII Proteoforms, Plasma Lipids, and Cardiovascular Risk in MESA.
Sinari S, Koska J, Hu Y, Furtado J, Jensen M, Budoff M
Arterioscler Thromb Vasc Biol. 2023; 43(8):1560-1571.
PMID: 37317850
PMC: 10516344.
DOI: 10.1161/ATVBAHA.123.319035.
Broadening the Scope of Dyslipidemia Therapy by Targeting APOC3 (Apolipoprotein C3) and ANGPTL3 (Angiopoietin-Like Protein 3).
Ginsberg H, Goldberg I
Arterioscler Thromb Vasc Biol. 2022; 43(3):388-398.
PMID: 36579649
PMC: 9975058.
DOI: 10.1161/ATVBAHA.122.317966.
Breast Meat Fatty Acid Profiling and Proteomic Analysis of Beijing-You Chicken During the Laying Period.
Zhang J, Zhuang H, Cao J, Geng A, Wang H, Chu Q
Front Vet Sci. 2022; 9:908862.
PMID: 35782537
PMC: 9240433.
DOI: 10.3389/fvets.2022.908862.
Interventional hepatic apoC-III knockdown improves atherosclerotic plaque stability and remodeling by triglyceride lowering.
Ramms B, Patel S, Sun X, Pessentheiner A, Ducasa G, Mullick A
JCI Insight. 2022; 7(13).
PMID: 35653195
PMC: 9310539.
DOI: 10.1172/jci.insight.158414.
Is apoCIII-Lowering A Double-Edged Sword?.
Tang X, Zhou H, Yan H, Niimi M, Fan J
J Atheroscler Thromb. 2022; 29(7):1117-1124.
PMID: 35545534
PMC: 9252641.
DOI: 10.5551/jat.LE002.
Genetically Engineered Hamster Models of Dyslipidemia and Atherosclerosis.
Xian X, Wang Y, Liu G
Methods Mol Biol. 2022; 2419:433-459.
PMID: 35237980
DOI: 10.1007/978-1-0716-1924-7_26.
Lipoprotein size is a main determinant for the rate of hydrolysis by exogenous LPL in human plasma.
Kovrov O, Landfors F, Saar-Kovrov V, Naslund U, Olivecrona G
J Lipid Res. 2021; 63(1):100144.
PMID: 34710432
PMC: 8953621.
DOI: 10.1016/j.jlr.2021.100144.
ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials.
Calle R, Amin N, Carvajal-Gonzalez S, Ross T, Bergman A, Aggarwal S
Nat Med. 2021; 27(10):1836-1848.
PMID: 34635855
DOI: 10.1038/s41591-021-01489-1.
The Importance of Lipoprotein Lipase Regulation in Atherosclerosis.
Kumari A, Kristensen K, Ploug M, Lund Winther A
Biomedicines. 2021; 9(7).
PMID: 34356847
PMC: 8301479.
DOI: 10.3390/biomedicines9070782.
Obesity Affects HDL Metabolism, Composition and Subclass Distribution.
Stadler J, Lackner S, Morkl S, Trakaki A, Scharnagl H, Borenich A
Biomedicines. 2021; 9(3).
PMID: 33673728
PMC: 7997277.
DOI: 10.3390/biomedicines9030242.
Apolipoprotein CIII and Angiopoietin-like Protein 8 are Elevated in Lipodystrophy and Decrease after Metreleptin.
Lightbourne M, Wolska A, Abel B, Rother K, Walter M, Kushchayeva Y
J Endocr Soc. 2021; 5(2):bvaa191.
PMID: 33442570
PMC: 7787426.
DOI: 10.1210/jendso/bvaa191.
Apolipoprotein CIII Deficiency Protects Against Atherosclerosis in Knockout Rabbits.
Yan H, Niimi M, Matsuhisa F, Zhou H, Kitajima S, Chen Y
Arterioscler Thromb Vasc Biol. 2020; 40(9):2095-2107.
PMID: 32757647
PMC: 7484272.
DOI: 10.1161/ATVBAHA.120.314368.
Emerging Targets for Cardiovascular Disease Prevention in Diabetes.
Stitziel N, Kanter J, Bornfeldt K
Trends Mol Med. 2020; 26(8):744-757.
PMID: 32423639
PMC: 7395866.
DOI: 10.1016/j.molmed.2020.03.011.
A dual apolipoprotein C-II mimetic-apolipoprotein C-III antagonist peptide lowers plasma triglycerides.
Wolska A, Lo L, Sviridov D, Pourmousa M, Pryor M, Ghosh S
Sci Transl Med. 2020; 12(528).
PMID: 31996466
PMC: 8359806.
DOI: 10.1126/scitranslmed.aaw7905.
Is APOC3 the driver of cardiovascular disease in people with type I diabetes mellitus?.
Ginsberg H, Reyes-Soffer G
J Clin Invest. 2019; 129(10):4074-4076.
PMID: 31449060
PMC: 6763265.
DOI: 10.1172/JCI131333.
